← Back to headlines
Eli Lilly Price Target Raised After FDA Approval for Fundayo
Eli Lilly and Company (LLY) saw its price target raised by analysts following the FDA's approval of its new drug, Fundayo.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
